Hikma Agrees to Buy EIMC United Pharmaceutical in Egypt

Hikma has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals from a consortium of shareholders to strengthen position in Egypt.

* Expands portfolio in oncology and injectables, with the potential to add around 50 products by 2020. Source: Bloomberg